CMSA Announcement Newsletter

Case Management Society of America

V.A.C. Therapy
KCI V.A.C.© NEGATIVE PRESSURE WOUND THERAPY MEDICARE PART B REIMBURSEMENT FACTS:
  To learn the facts, contact your Acelity representative or visit npwtcompetitivebidding.com for an on-demand webinar.
  • V.A.C.© Therapy is still available to patients
  • V.A.C.© Therapy did not lose Medicare coverage
  • KCI is working with contracted suppliers to provide V.A.C.© Therapy for patients served in CMS Round 2 recompete competitive bidding areas (CBAs)
To learn the facts, contact your Acelity representative or visit npwtcompetitivebidding.com for an on-demand webinar.
Who should attend? WOCNs, Case Managers, Social Workers, Discharge Planners, and any healthcare professional involved with ordering or transitioning patients to the home care setting.
FROM HOSPITAL TO HOME, CLINICIANS ARE CONFIDENT IN THE CERTAINTY OF ACELITY™.
10 million wounds treated worldwide with V.A.C.© Therapy*
SENSAT R.A.C. Technology with EasyClear™ Purge Technology, demonstrates Acelity's industry leadership
Over 158,000 Medicare Patients** since competitive bidding was implemented in 2013
95% of Published NPWT Clinical Evidence is based on V.A.C.© Therapy**
400 Clinically Trained Representatives support therapy outcomes
Dedicated Team of 65 Nurses monitor patient progress
The Certainty of Acelity™
*As of June 2016, KCI data on file.
**KCI data on file.
  KCI
NOTE: Specific indications, contraindications, warnings, precautions, and safety information exist for KCI products and therapies. Please consult a physician and product instructions for use prior to application. Rx only.

 ©2016 KCI Licensing, Inc. All rights reserved. All trademarks designated herein are proprietary to KCI Licensing, Inc. DSL#16-0634.US (Rev. 8/16)
Acelity